11
MSD LYBIA BONE BUSINESS REVIEW

Motaz lybia 2014 final

Embed Size (px)

Citation preview

Page 1: Motaz lybia 2014 final

MSD LYBIA BONE BUSINESS REVIEW

Page 2: Motaz lybia 2014 final
Page 3: Motaz lybia 2014 final

Market over viewTotal potential Account number (private

+public) in average 250 COVERAGE ACCOUNT

Total potential pharmacies in averageClass TRIPOLI MASRATA BENGHAZIA 160 40 80B 340 130 220TOTAL (970)

500 170 300

Total coverage all specialties in averageAREA TRIPOLI

(WEST)BENGHAZI (EAST)

TOTAL

NUMBER 1550 650 2200

Page 4: Motaz lybia 2014 final

BONE LINE COVERAGE IN 2014SP. TRIPOLI

(WEST AREA)

BENGHAZI(EAST AREA|)

TOTAL K.O.L

SPEAKER

ORTHOPEDIC 200 50 250 7 1RHUMATOLOGY 18 9 27 3ENDOCRINOLOGY(OSTEOPOROSISE)

7 3 10 2

NEURO SURG. 10 5 15 3GP (IM) 20 8 27

TOTAL 330

Page 5: Motaz lybia 2014 final

ARCOXIA 2010 (7 TABLET)

ARCOXIA 2012 (7 TABLET)

ARCOXIA2013 (7,14 TABLET)

0 10000 20000 30000 40000 50000 60000

ARCOXIA

2013 GR% 326%

Page 6: Motaz lybia 2014 final

2014 GR% +4%

y 2013 y 2014515005200052500530005350054000545005500055500

Arcoxia

Axis Title

37524 17457

GR % +42 packs

14 tab.packs 7 &14 tab,

Page 7: Motaz lybia 2014 final

24%

29%

46%

ARCOXIAARC 60 ARC90 ARC 120

Page 8: Motaz lybia 2014 final

2014 success story PenetrationAll sectors

Tender(mso –

hospitals direct orders)

Private big accounts polyclinics

Page 9: Motaz lybia 2014 final

FOSAVANCE FOSAMAX0200400600800

10001200

2014

Page 10: Motaz lybia 2014 final

Libya standalone

Dubai 16 customer

Barcelona 4 customer

Page 11: Motaz lybia 2014 final

2015